Previous 10 | Next 10 |
2023-12-19 20:38:32 ET Summary AVITA Medical's Spray-On Skin Cells device rapidly processes a patient's own skin to treat large dermatological injuries. The company's sales growth is expected to accelerate in 2024 due to the supplement of its RECELL System for full-thickness skin ...
VALENCIA, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today ann...
2023-11-21 09:59:42 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector a...
2023-11-20 16:52:50 ET Shares of Avita Medical ( NASDAQ: RCEL ) on Monday slumped as much as 11.4% in extended trading, after the skin restoration-focused pharmaceutical company cut its full year 2023 commercial revenue guidance. RCEL stock had cut back the losses and was la...
VALENCIA, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today ann...
2023-11-10 10:00:34 ET DENVER, Colo., Nov. 10, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Motus GI Holdings Inc (NASDAQ: MOTS), Blink Charging Co (NASDAQ: BLNK), Navitas Semiconductor Corp (NASDA...
2023-11-10 10:00:06 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom September Labor Report Preview: Full Employ...
2023-11-09 20:39:04 ET AVITA Medical, Inc. (RCEL) Q3 2023 Results Conference Call November 09, 2023 04:30 PM ET Company Participants Jessica Ekeberg - Director of Investor Relations Jim Corbett - Chief Executive Officer David O’Toole - Chief Financial Offi...
2023-11-09 16:06:26 ET AVITA Medical press release ( NASDAQ: RCEL ): Q3 GAAP EPS of -$0.34 beats by $0.10 . Revenue of $13.5M (+48.5% Y/Y) beats by $0.21M . Commercial revenue for the fourth quarter 2023 is expected to be in the range of $15.3 to $16.3 million....
VALENCIA, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “ Company ”), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, tod...
News, Short Squeeze, Breakout and More Instantly...
VALENCIA, Calif., July 11, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that it will report its second quarter 2024 financia...
VALENCIA, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that the Joseph M. Still Burn Center at Doctors Hosp...
2024-06-02 14:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...